Pharmaceutical Business review

ICON Q2 revenue rises

For the second quarter of 2011, the company has generated net income of $13.08m, compared to $22.87m for the same period in 2010.

ICON’s income from operations was $15.51m, compared to $25.68m for the same period last year.

For the six months ended 30 June 2011, the company posted net revenue of $462.34m, compared to $442.86m for the same period in 2010.

Net income was $25.89m for the six months of 2011 compared to $45.07m in the prior year period.

The company’s income from operations was $31.48m, compared to $52.46m for the same period in 2010.